Chad E. Davis counsels companies, investors, and entrepreneurs on IP matters, especially patent matters. He has extensive experience in prosecution and strategic development of worldwide patent portfolios, IP due diligence, risk assessment through, for example, validity and infringement analyses, post-grant patent proceedings, and IP contracts. Davis represents clients in a diverse range of technologies, including pharmaceuticals, drug delivery technologies, crystal forms, organic dyes, chemical processes, polymers, proteins, antibodies, stem cell technology, medical diagnostics, medical imaging, microfluidic devices, adhesives, analytical chemistry, foams, cosmetics, and optical technologies. For companies developing pharmaceuticals, Davis provides counsel through all aspects of the business cycle.